Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vaccine. 2005 Jul 14;23(32):4110-9. Epub 2005 Apr 12.

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.

Author information

  • 1School of Public Health, Faculty of Medicine, University of Chile, Santiago, Chile.

Abstract

Hepatitis A is an important public health problem in Chile. Childhood vaccination has reduced hepatitis A rates in several countries, prompting this evaluation of its cost-effectiveness in Chile. Using a Markov model, we project mass vaccination would reduce hepatitis A cases among birth cohort members and their personal contacts >80%. Vaccination costs of US dollars 5.3-6.4 million would be offset by US dollars 9.2-9.4 million reductions in disease costs. Further, approximately 70 fatal infections would be averted and >4600 quality-adjusted life years would be saved. This analysis supports the cost-effectiveness of universal childhood hepatitis A vaccination in Chile.

PMID:
15964479
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk